DREAM: A phase 2 trial of durvalumab with first line chemotherapy in mesothelioma with a safety run in
DREAM: A phase 2 trial of durvalumab with first line chemotherapy in mesothelioma with a safety run in
Press Ctrl +⌘ + to increase font size.
Press Ctrl -⌘ - to decrease font size.
Press Ctrl 0⌘ 0 to reset font size.